BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5330548)

  • 1. The role of catecholamines in specific psychiatric disorders.
    Friedhoff AJ; Van Winkle E
    Res Publ Assoc Res Nerv Ment Dis; 1966; 43():366-70. PubMed ID: 5330548
    [No Abstract]   [Full Text] [Related]  

  • 2. [A fascinating prospect: psychiatric biology].
    Fazio C
    Minerva Med; 1972 Feb; 63(13):755-6. PubMed ID: 5013641
    [No Abstract]   [Full Text] [Related]  

  • 3. Catecholamines in neuropsychiatric states.
    Kety SS
    Pharmacol Rev; 1966 Mar; 18(1):787-98. PubMed ID: 5323770
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of human growth hormone secretion in sleep and waking.
    Mendelson WB
    Int Rev Neurobiol; 1982; 23():367-89. PubMed ID: 6126463
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular organicity of abnormal behaviors and mental disorders].
    Laborit H
    Agressologie; 1972; 13(2):83-91. PubMed ID: 4342791
    [No Abstract]   [Full Text] [Related]  

  • 6. Preface. The Tenth International Catecholamine Symposium (XICS).
    Eiden LE
    Adv Pharmacol; 2013; 68():xiii-xv. PubMed ID: 24054158
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of phenol excretion in clinical psychiatry. II. Total, free, conjugated, acid, volatile phenols and vanyl-mandelic acid].
    Enkin M; Treuil J; Bécache A; Revol L
    Encephale; 1966; 55(5):391-451. PubMed ID: 6008261
    [No Abstract]   [Full Text] [Related]  

  • 8. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry.
    Pacchierotti C; Iapichino S; Bossini L; Pieraccini F; Castrogiovanni P
    Front Neuroendocrinol; 2001 Jan; 22(1):18-32. PubMed ID: 11141317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current viewpoints of psychiatric disorders].
    van Ree JM
    Ned Tijdschr Geneeskd; 1984 Jul; 128(27):1299-302. PubMed ID: 6146934
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of corticotropin-releasing factor family peptides and receptors in stress-related psychiatric disorders.
    Clark MS; Kaiyala KJ
    Semin Clin Neuropsychiatry; 2003 Apr; 8(2):119-36. PubMed ID: 12728411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Dopamine and psychiatric states: preliminary remarks.
    Angrist BM; Gershon S
    Psychopharmacol Bull; 1974 Jul; 10(3):15. PubMed ID: 4419355
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders--focus on magnetic resonance spectroscopy (MRS) studies.
    Kim H; McGrath BM; Silverstone PH
    Hum Psychopharmacol; 2005 Jul; 20(5):309-26. PubMed ID: 15880397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of phosphodiesterases in neurological and psychiatric disease.
    Hebb AL; Robertson HA
    Curr Opin Pharmacol; 2007 Feb; 7(1):86-92. PubMed ID: 17113826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chlorides in the cerebrospinal fluid in psychiatric diseases].
    Pogády J; Hudáková G
    Cesk Psychiatr; 1965 Jun; 61(3):156-62. PubMed ID: 5837217
    [No Abstract]   [Full Text] [Related]  

  • 15. [Excretion of 5-hydroxyindoleacetic acid and vanilmandelic acid in patients with glaucoma].
    Dienstbier E; Balík J; Duchon J; Fischer O
    Cesk Oftalmol; 1967 May; 23(3):177-86. PubMed ID: 5586682
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of psychiatric inpatients and outpatients and malvaria.
    Hoffer A
    Int J Neuropsychiatry; 1965 Oct; 1(5):430-2. PubMed ID: 5858882
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on free aminoacids and sugars in cerebrospinal fluid and serum in neuro-psychiatric disorders by circular chromatographic technique.
    Rao BS
    Neurol India; 1970 Mar; 18(1):13-6. PubMed ID: 5439379
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship between metals in the body and psychiatric disorders].
    Sirota P; Kaspi N
    Harefuah; 1993 Nov; 125(10):353-5. PubMed ID: 8253403
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the HPA axis in psychiatric disorders and CRF antagonists as potential treatments.
    Keller PA; McCluskey A; Morgan J; O'connor SM
    Arch Pharm (Weinheim); 2006 Jul; 339(7):346-55. PubMed ID: 16783839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aldolase activity of the blood and cerebrospinal fluid in various neurological and psychiatric diseases].
    Rizzo PA; Amabile G
    Riv Neurol; 1966; 36(4):407-16. PubMed ID: 5968445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.